ArticleBreast cancer research : BCR2002
Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo.
Article in Breast cancer research : BCR, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 32 citations in OpenAlex.
- The Role of Extracellular Matrix Proteins in Breast Cancer.Journal of clinical medicine · 2022Review
- Genetic Drivers of Ileal Neuroendocrine Tumors.Cancers · 2021Review
- Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression.Journal of mammary gland biology and neoplasia · 2018Review
- CPEB1 promotes differentiation and suppresses EMT in mammary epithelial cells.Journal of cell science · 2014Article
- Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.International journal of oncology · 2012Article
- Cell-matrix interactions in mammary gland development and breast cancer.Cold Spring Harbor perspectives in biology · 2010Review
- Myoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice.Journal of mammary gland biology and neoplasia · 2005Review
- Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer.World journal of gastroenterology · 2004Article
- Article
- Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.British journal of cancer · 2003Article
- The importance of being a myoepithelial cell.Breast cancer research : BCR · 2002Review
- Normal morphogenesis of epithelial tissues and progression of epithelial tumors.Wiley interdisciplinary reviews. Systems biology and medicineReview
- Aberrant methylation of the maspin promoter is an early event in human breast cancer.Neoplasia (New York, N.Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maspin is a member of the serpin family of serine proteases and functions as a tumour suppressor. A study using a new syngeneic mouse model for breast cancer suggests that maspin can inhibit metastasis in vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.